Short-term Changes in Aortic Regurgitation after Percutaneous Mitral Valvuloplasty
sedigheh saedi
1
,
Mona Heidarali
1
,
Tehereh Saedi
1
, *
,
Homman Bakhshandeh Abkenar
1
and
Mohammad Ali Sadr-Ameli
1
1 Department of Cardiology, Rajaei Cardiovascular, Medical and Research Centre, Tehran University of Medical Sciences, Tehran, Iran
*
Corresponding author: Tehereh Saedi , Department of Cardiology, Rajaei Cardiovascular, Medical and Research Centre, Tehran University of Medical Sciences, Tehran, Iran
sedighe@e.com
International Cardiovascular Research Journal: March 31, 2017,
7 (1) ; e12712
Published Online :
March 31, 2013
Article Type: Research Article
Received:
May 07, 2017
Accepted:
March 07, 2013
To Cite:
saedi
S, Heidarali
M , Saedi
T, Bakhshandeh Abkenar
H , Sadr-Ameli
M A . et al. Short-term Changes in Aortic Regurgitation after Percutaneous Mitral Valvuloplasty,
Int Cardio Res J.
2017
;7(1):e12712.
Abstract
Objectives: The aim of this study was to evaluate the short- term effects of percutaneous mitral valvuloplasty (PMV) on coexisting AR.
Methods: Clinical, echocardiographic and catheterization data from hospital records of a total of 327 patients with rheumatic mitral stenosis who underwent PMV at a tertiary centre were retrospectively reviewed and aortic regurgitation changes 48 hours post PMV was recorded.
Results: The study population consisted of 282 females and 45 males. Mean age at the time of intervention was 47.13±11 years. Before PMV, 142 (43.3%) patients had no AR, 124 (37.9%) had mild AR and 61 (18.7%) had moderate AR. There was no change in AR severity in post- PMV follow-up. AR progression after PMV and during the follow-up was not significant and there was no increase in the need for aortic valve replacement (AVR) procedures.
Conclusions: Our findings indicated that a considerable number of patients with rheumatic mitral stenosis had concurrent AR. At the time of PMV concomitant AR does affect procedural success and is not associated with inferior outcomes. Patients with moderate degrees of AR remain good candidates for PMV.
© 0, Shiraz University of Medical Sciences.
References
1.
The references are available in PDF.
Except where otherwise noted, this work is licensed under
Creative Commons Attribution Non Commercial 4.0 International License .
Comments